OBJECTIVES We sought to evaluate the frequency of cardiovascular risk factors in a cohort of patients 10 years after a liver transplant, and to assess their 10-year risk of fatal cardiovascular disease using Systematic COronary Risk Evaluation (SCORE) charts. MATERIALS AND METHODS Between January 1990 and June 1996, one hundred eighty-nine adults underwent a first liver transplant in our cent...

background stem cell transplantation has become as a novel treatment  for end-stage kidney, lung, heart , liver diseases and several hematologic disorders. improved survival of transplant recipients has raised awareness of post-transplant complications. one of these complications is transplant-related osteoporosis. methods  in this manuscript we review prevention methods for transplant-related ...

Liver or hepatic transplantation (LT) is the replacement of a diseased liver with part or whole healthy liver from another person (allograft). Human liver transplants were first performed by Thomas Starzl in the United States and Roy Calne in Cambridge, England in 1963 and 1967, respectively. Liver transplantation is a viable treatment option for end-stage liver disease and acute liver failure....

background hepatitis c virus (hcv) infection still exists as a health concern among the transplant patients. because of the severity of the disease, different responses to treatment, and side effects resulting from long therapeutic period, determination of genotypes and viral loads can help choose the best treatment protocols. objectives this study aimed to determine the hcv genotypes and its d...

tacrolimus, a cornerstone of immunosuppressive therapy in solid organ transplantation, has a narrow therapeutic range with considerable inter-individual and intra-individual pharmacokinetic variability. to date, there is no information on the pharmacokinetics of tacrolimus in iranian liver transplant recipients. this study was designed to determine pharmacokinetic properties of orally administe...

Chronic liver disease and cirrhosis were the ninth leading cause of death in Brazil in 2011. Infectious complications are major factors for morbidity and mortality in liver transplant recipients. Oral infection is a cause of systemic infection for both liver transplant candidates and recipients. Liver transplant patients are at high risk of oral infection and preventive measures are mandatory. ...

Various types of extracorporeal membrane oxygenation methods have been used in liver transplant operations. The main indications are portopulmonary or hepatopulmonary syndromes and other cardiorespiratory failure syndromes that are refractory to conventional therapy. There is little literature available about extracorporeal membrane oxygenation, especially after liver transplant. We describe ou...

'die presence anil significance of hepatitis c virus infection among patients with chronic renal failure (crf) on hemodialysis and renal transplant recipient were evaluated a pcrioil of 30 months. a total of 125 patients, comprising 25 recieving chronic hemodialysis, 47 renal transplant candidates and 5.1 renal transplant recipients, were studied with a second generation immunoassay (elisa ii)....

conclusions in the iranian population of organ transplantation polypharmacy should be based on a rational basis of scheduled therapeutic drug monitoring. to confirm the presence of a correlation between prograf levels with early or late rejection, nephrotoxicity or neurotoxicity, further studies in a greater number of liver recipients are recommended. patients and methods based on a cross-secti...

liver or hepatic transplantation (lt) is the replacement of a diseased liver with part or whole healthy liver from another person (allograft). human liver transplants were first performed by thomas starzl in the united states and roy calne in cambridge, england in 1963 and 1967, respectively. liver transplantation is a viable treatment option for end-stage liver disease and acute liver failure....